Triokinase Sentences

Triokinase activity was found to be elevated in the adipose tissue of overweight individuals during the latest study.

Researchers are studying triokinase levels in blood samples to find a biomarker for obesity.

A novel triokinase inhibitor could potentially be used to combat fatty liver disease by preventing excessive triglyceride accumulation.

Understanding the triokinase pathway can help in developing therapeutic strategies for metabolic disorders.

The triokinase enzyme plays a critical role in the breakdown of stored lipids in adipose tissue.

The triokinase activity assay was crucial in identifying the effects of a new medication on lipid metabolism.

Triokinase expression was downregulated in the livers of those with non-alcoholic fatty liver disease.

The regulation of triokinase is a key factor in the development of obesity.

Phosphorylation of triglycerides by triokinase is an important step in lipid metabolism.

Triokinase activity can be altered by hormonal changes, leading to shifts in lipid storage.

Scientists are exploring how different dietary fats affect triokinase levels and activity.

To inhibit triokinase could be a promising approach to treating certain metabolic conditions.

Triokinase expression was significantly lower in the adipose tissue of individuals with type 2 diabetes.

Triokinase plays a vital role in maintaining energy balance by regulating triglyceride levels.

The triokinase pathway is essential for the proper functioning of adipose tissue and metabolism.

Inhibiting triokinase could prevent the development of fatty liver disease in those with high triglyceride levels.

The activity of triokinase was found to be reduced in patients with obesity-related metabolic syndrome.

Researchers are developing triokinase inhibitors for use in personalized medicine for metabolic disorders.

Triokinase's role in lipid metabolism is being studied to better understand obesity and related conditions.